The pharma ecosystem is changing rapidly and will continue to do so in the foreseeable future. The complicated healthcaresystems in the US, new technologies and methodologies to generate insights have forced pharma/biotechs to move beyond the reach/frequency model to deeply rethink how they deploy their sales and marketing channels.
This interactive workshop will draw upon the cutting edge practices from across the spectrum of therapy areas (e.g. oncology, rare, ultra-rare, and gene therapy) to provide actionable insights on:
Omnichannel customer engagement is the new mantra in pharma, with every interaction influencing the next interaction, and with campaign content building blocks tailored per segment, per message and per individual customer.
Making omnichannel successful requires robust omnichannel data (channel/content/context affinities), a tailored strategy, flawless execution, and continuous interaction and impact tracking. Over the years, Across Health, a global omnichannel consult-agency for life sciences, has developed an integrated “soup to nuts” (insight through to impact) offering, leveraging its unique Navigator customer insights (used by over 30 companies).
In this workshop we will demonstrate step by step how to leverage the Navigator data for designing an optimal omnichannel HCP business case and strategy, how to plan for impact, and how to ensure robust execution. We will also highlight a robust business case validated by IMS data and offer you a blueprint approach on how to do this for your campaigns as well.
Workshop Leader – Ruud Kooi, Managing Partner, Across Health